Peking Union Medical College Hospital

elsewhere's corpus does not cover Peking Union Medical College Hospital as a subject in its own right. The only mentions in the bundle are as a clinical collaborator for several portfolio companies: Shukun Technology (AI medical imaging, per 5Y Capital) , Unknown (AI microbiome drug development, per 5Y Capital and Gaorong Ventures) , and CAS-Ruiyi (neurological disease diagnosis, per BlueRun Ventures) . These references position it as a top-tier public hospital in Beijing that partners with startups on clinical trials and joint innovation centers, but no founding date, size, or institutional profile is provided.